
Raymond James lowered its price target on Quidel (QDEL) to $55 from $60, while maintaining an Outperform rating, despite the company reporting a strong latest quarter with revenues largely in line and margins exceeding expectations. The stock, currently trading near its 52-week low, still offers significant upside to the new target. This positive analyst outlook is contrasted by the stock's 1.78% decline following the release of its Q2 2025 results, which included an impressive EPS beat and revenue surpassing forecasts, highlighting mixed investor sentiment.
Quidel Corp. (QDEL) presents a significant disconnect between its recent operational performance and its market valuation. Analyst firm Raymond James, while reducing its price target to $55 from $60, maintained an Outperform rating, citing a "strong and fairly clean quarter." The company's financial results underscore this strength, with EBITDA reaching $107 million on a 17.4% margin, surpassing the consensus estimate of $95 million on a 15.5% margin. This margin beat occurred even as revenue was merely in-line with expectations. The decision to reiterate guidance is viewed by the analyst as a prudent move reflecting a "show me story," with underlying adjustments removing a previously assumed Q3 COVID spike, suggesting a more conservative and potentially durable baseline. Despite these positive fundamentals and a reported EPS of $0.12 for its Q2 2025—a 7900% surprise over forecasts—the stock declined 1.78% and continues to trade near its 52-week low of $22.05. This negative investor reaction highlights deep skepticism, creating a wide valuation gap, as the new $55 price target still implies dramatic upside from the current price of $23.68.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment